Stocks and InvestingStocks and Investing
Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022
Thu, May 12, 2022

Tiago Fauth Maintained (ASND) at Buy with Decreased Target to $123 on, May 12th, 2022


Published on 2024-10-27 21:02:32 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $194 to $123 on, May 12th, 2022.

Tiago has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Tiago


  • Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $161 on, Tuesday, March 15th, 2022
  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $117 on, Thursday, March 3rd, 2022
  • Leland Gershell of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $170 on, Monday, February 14th, 2022